Markus S. Anker
Humboldt-Universität zu Berlin(DE)Berlin-Brandenburger Centrum für Regenerative Therapien(DE)German Centre for Cardiovascular Research(DE)Deutsches Herzzentrum München(DE)University of Glasgow(GB)
Publications by Year
Research Areas
Heart Failure Treatment and Management, Nutrition and Health in Aging, Cardiovascular Function and Risk Factors, Chemotherapy-induced cardiotoxicity and mitigation, Muscle Physiology and Disorders
Most-Cited Works
- → Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society(2020)734 cited
- → Clinical Practice Update on Heart Failure 2019: Pharmacotherapy, Procedures, Devices and Patient Management. An Expert Consensus Meeting Report of the Heart Failure Association of the European Society of Cardiology(2019)602 cited
- → Role of Cardiovascular Imaging in Cancer Patients Receiving Cardiotoxic Therapies: A Position Statement on Behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)(2020)351 cited
- → Role of Serum Biomarkers in Cancer Patients Receiving Cardiotoxic Cancer Therapies: A Position Statement from the Cardio-Oncology Study Group of the Heart Failure Association and the Cardio-Oncology Council of the European Society of Cardiology(2020)328 cited
- → Prevalence and clinical impact of cachexia in chronic illness in Europe, USA, and Japan: facts and numbers update 2016(2016)316 cited